MTS Medication Tech. (MTSI) Reports Q3 Earnings

February 17, 2009 8:06 AM EST

MTS Medication Technologies, Inc. (Nasdaq: MTSI) reports Q3 EPS of $0.10, compared to $0.09 in the same quarter last year. Revenue for the quarter was $19.2 million, versus the consensus of $20.70 million.


Related Categories

Earnings

Stocks Mentioned

MTSI 5.64

-0.01 -0.18%
Volume: 9,600
Track MTSI


Add Your Comment